Revelation Biosciences, Inc. REVBW
Set alert
As of Oct 27, 1:09 PM ET
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0125
- Prev close
- 0.0057
- Mkt cap
- 31.40K
- Vol
- 23.25K
- Avg vol
- 0
- EPS
- -4.77
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0053
- High
- 0.0057
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.01
- EPS (TTM)
- -4.77
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -6.49M
- Total cash
- 6.54M
- Total debt
- 0
- Return on equity
- -270.02%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- revbiosciences.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on REVBW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Linden Advisors LP | 10.46% | 338,110 | 2.23K | Sep 29, 2024 |
| Yakira Capital Management, Inc. | 7.64% | 246,884 | 1.63K | Sep 29, 2024 |
| Walleye Capital LLC | 5.78% | 187,001 | 1.23K | Sep 29, 2024 |
| Pine Valley Investments Ltd Liability Co. | 4.40% | 142,148 | 938 | Sep 29, 2024 |
| Walleye Trading LLC | 3.25% | 104,990 | 692 | Sep 29, 2024 |
| Cowen and Company, LLC | 3.09% | 99,900 | 659 | Sep 29, 2024 |